Direct healthcare costs associated with management of asthma: comparison of two treatment regimens in Indonesia, Thailand and Vietnam.
Bhumika AggarwalPaul W JonesFaisal YunusLe Thi Tuyet LanWatchara BoonsawatAfisi IsmailaSibel AsciogluPublished in: The Journal of asthma : official journal of the Association for the Care of Asthma (2021)
In the three countries evaluated, total treatment costs with regular twice-daily FP/salm were consistently lower than with budesonide/formoterol MART due to lower direct healthcare costs.